Related Experiment Video
Updated: Jul 11, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
Published on: December 10, 2012
A Bayesian mixture model for metaanalysis of microarray studies
1Department of Mathematics and Statistics, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 01003-9305, USA. econlon@mathstat.umass.edu
Abstract:
The increased availability of microarray data has been calling for statistical methods to integrate findings across studies. A common goal of microarray analysis is to determine differentially expressed genes between two conditions, such as treatment vs control. A recent Bayesian metaanalysis model used a prior distribution for the mean log-expression ratios that was a mixture of two normal distributions. This model centered the prior distribution of differential expression at zero, and separated genes into two groups only: expressed and nonexpressed. Here, we introduce a Bayesian three-component truncated normal mixture prior model that more flexibly assigns prior distributions to the differentially expressed genes and produces three groups of genes: up and downregulated, and nonexpressed. We found in simulations of two and five studies that the three-component model outperformed the two-component model using three comparison measures. When analyzing biological data of Bacillus subtilis, we found that the three-component model discovered more genes and omitted fewer genes for the same levels of posterior probability of differential expression than the two-component model, and discovered more genes for fixed thresholds of Bayesian false discovery. We assumed that the data sets were produced from the same microarray platform and were prescaled.
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
DNA Microarrays
Methods of Medium Optimization
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

